Central angiotensin AT1-receptor blockade affects thermoregulation and running performance in rats

• DOI: 10.1152/ajpregu.00038.2006
• Publication Date: 2006-04-14T00:55:30Z
• Authors: Laura H. R. Leite; Ana Cristina R. L...; Umeko Marubayashi; Cândido C. Coimbra
• Keywords: Male; Tail; 0301 basic medicine; Physical Exertion; Losartan; Receptor, Angiotensin, Type 1; Rats; Running; 3. Good health; 03 medical and health sciences; Physical Conditioning, Animal; Animals; Rats, Wistar; Angiotensin II Type 1 Receptor Blockers; Body Temperature Regulation

The effect of central angiotensin AT1-receptor blockade on thermoregulation in rats during exercise on a treadmill (18 m/min, 5% inclination) was investigated. Core (Tb) and skin tail temperatures were measured in rats while they were exercising until fatigue after injection of 2 μl of losartan (Los; 20 nmol, n = 4; 30 nmol, n = 4; 60 nmol, n = 7), an angiotensin II AT1-receptor antagonist, or 2 μl of 0.15 mol/l NaCl (Sal; n = 15) into the right lateral cerebral ventricle. Body heat rate (BHR), heat storage rate, threshold Tb for tail vasodilation (TTbV), time to fatigue, and workload were calculated. During exercise, the BHR and heat storage rate of Los-treated animals were, respectively, 40 and 53% higher ( P < 0.01) than in Sal-treated animals. Additionally, rats injected with Los showed an increased TTbV (38.59 ± 0.19°C for Los vs. 38.12 ± 0.1°C for Sal, P < 0.02), a higher Tb at fatigue point (39.07 ± 0.14°C Los vs. 38.66 ± 0.07°C Sal, P < 0.01), and a reduced running performance (27.29 ± 4.48 min Los vs. 52.47 ± 6.67 min Sal, P < 0.01), which was closely related to the increased BHR. Our data suggest that AT1-receptor blockade attenuates heat dissipation during exercise due to the higher TTbV, leading to a faster exercise-induced increase in Tb, thus decreasing running performance.